127.00
127.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
FANID 20 TAB contains Famotidine 20 mg, an H2-receptor antagonist used to treat and prevent gastric ulcers, gastroesophageal reflux disease (GERD), and hyperacidity-related disorders. It works by reducing stomach acid secretion, providing effective relief from heartburn, indigestion, and acid reflux symptoms. Manufactured by BluepillExpress, the formulation meets stringent international quality standards and is suitable for global export under private labeling and third-party agreements.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
FANID 20 TAB is a potent and selective H2-receptor antagonist that contains Famotidine 20 mg, designed to treat a wide range of gastrointestinal disorders associated with excessive gastric acid secretion. Famotidine inhibits histamine action at the H2-receptors of the gastric parietal cells, thereby decreasing the volume and concentration of stomach acid produced.
This medicine is widely prescribed for peptic ulcers, erosive esophagitis, GERD, and Zollinger-Ellison Syndrome. It provides both symptomatic relief and clinical healing of acid-related damage in the upper gastrointestinal tract. Unlike proton pump inhibitors, Famotidine offers faster onset of action and is commonly used for immediate acid suppression.
FANID 20 TAB is manufactured by BluepillExpress, a globally trusted name in pharmaceutical contract manufacturing, known for precision, compliance, and international supply chain capabilities. The product is offered in WHO-GMP and ISO-certified facilities with options for regulatory support for global markets.
Therapeutic Uses
Short-term treatment of active duodenal and gastric ulcers
Management and maintenance of gastroesophageal reflux disease (GERD)
Treatment of heartburn, indigestion, and acid reflux
Control of pathological hypersecretory conditions like Zollinger-Ellison Syndrome
Prevention of stress ulcers in hospitalized patients
Adjunct in the Helicobacter pylori eradication regimen (as part of combination therapy)
Mechanism of Action
Famotidine selectively blocks histamine H2-receptors on the gastric parietal cells, which significantly inhibits both basal and stimulated gastric acid secretion. It reduces both the volume and acidity of gastric output, leading to ulcer healing and symptom relief.
Its onset of action typically begins within 1 hour, with peak effect occurring within 1–3 hours after administration. The acid-suppressing effect lasts up to 12 hours, making it suitable for twice-daily or once-daily dosing based on severity.